Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02561819 · ClinicalTrials.gov registry record
Measurement of Body Composition by Air Displacement Plethysmography in Pediatric Intestinal Failure Patients
A clinical trial of Short Bowel Syndrome, sponsored by Christopher Duggan.
- Completed
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT02561819 is a study of Short Bowel Syndrome that has completed, run by Christopher Duggan. The registered enrollment target is 25 participants, below the 183-participant average among 17 other Short Bowel Syndrome trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02561819, a study of Short Bowel Syndrome, has completed, sponsored by Christopher Duggan.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will determine if air-displacement plethysmography (ADP) provides accurate measurement of body composition (percent body fat and fat-free mass) in pediatric patients with intestinal failure, as compared to body composition measured by alternative standard methods, including deuterium dilution, bioimpedance analysis (BIA), dual x-ray absorptiometry (DXA) when clinically indicated, and routine anthropometric measurements.
Conditions Studied
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2015-11 |
| Est. Completion | 2020-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02561819
The ClinicalTrials.gov registry entry for NCT02561819 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 183-participant average among 17 other Short Bowel Syndrome trials with a reported enrollment target (86% lower). The listed sponsor is Christopher Duggan, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Short Bowel Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT02561819 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02561819 about?
NCT02561819 is a clinical study titled "Measurement of Body Composition by Air Displacement Plethysmography in Pediatric Intestinal Failure Patients". This study will determine if air-displacement plethysmography (ADP) provides accurate measurement of body composition (percent body fat and fat-free mass) in pediatric patients with intestinal failure, as compared to body composition measured by alternative standard methods, including deuterium dilu...
What is the current status of trial NCT02561819?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2015-11. Estimated completion is 2020-12.
What conditions does trial NCT02561819 study?
This clinical trial studies the following conditions: Short Bowel Syndrome.
Who is sponsoring clinical trial NCT02561819?
This trial is sponsored by Christopher Duggan, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02561819 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Short Bowel Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome
RECRUITING · NA
-
Open-Label Pilot Study With Crofelemer in Patients With Short Bowel Syndrome
RECRUITING · Early Phase 1
-
Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects
RECRUITING · Phase 2
-
A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB
RECRUITING · NA
-
Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
RECRUITING · Phase 3
-
Registry for Participants With Short Bowel Syndrome
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.